Skip to content

Clinical implications of asymptomatic corneal shedding of herpes simplex virus

Clinical implications of asymptomatic corneal shedding of herpes simplex virus - CORSURV

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON48221
Enrollment
45
Registered
2020-01-15
Start date
2020-07-20
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

herpetic keratitis

Interventions

None listed

Sponsors

Erasmus MC, Universitair Medisch Centrum Rotterdam
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Age * 18 years. - Informed consent. - Immunecompetent individual. - Positive HSV-1 infection status - No symptomatic ocular HSV-1 disease during 3 months preceding first study sampling. - No anti-HSV therapy during 1 month preceding first study sampling. - No immunesuppressive drugs during the 3 months preceding first study sampling. - No previous keratoplasty

Exclusion criteria

Exclusion criteria: - Individual not able to adhere to bi-daily oral and corneal sampling for 30 consecutive days. - Individuals wearing contact lenses

Design outcomes

Primary

MeasureTime frame
Main study parameters/endpoints: Proportion of HSV-1 DNA positive oral and corneal samples.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)